Desmopressin vs Epithalon
Overview
Desmopressin is primarily a hormonal peptide, while Epithalon is used for sleep & recovery.
This page compares Desmopressin and Epithalon across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Desmopressin | Epithalon | |
|---|---|---|
| Category | Hormonal | Sleep & Recovery |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) | 5-10 mg |
| Frequency | Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia) | cycle protocol |
| Reported benefits | central diabetes insipidus management, primary nocturnal enuresis in children, nocturia due to nocturnal polyuria, perioperative hemostasis in mild hemophilia A, hemostasis in Type I von Willebrand disease, management of polyuria following head trauma or pituitary surgery | Improved sleep quality, circadian rhythm regulation, anti-aging |
| Reported side effects | hyponatremia (boxed warning), headache, facial flushing, nausea, abdominal cramps, fluid retention, hypotension, reflex tachycardia, hypertension, tachyphylaxis with repeated dosing, rare anaphylaxis | Minimal side effects during cycles |
Key differences
Primary use. Desmopressin is categorised under Hormonal, while Epithalon falls under Sleep & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Desmopressin: FDA-approved. Epithalon: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Desmopressin is typically dosed at 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) (Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia)). Epithalon is typically dosed at 5-10 mg (cycle protocol).
Can you stack them?
Some protocols combine peptides, but stacking Desmopressin and Epithalon has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Desmopressin and Epithalon?
- Desmopressin is primarily a hormonal peptide, while Epithalon is used for sleep & recovery. Desmopressin is FDA-approved for one or more indications, whereas Epithalon is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Desmopressin used for?
- Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders.
- What is Epithalon used for?
- Circadian rhythm regulator.
- Can you take Desmopressin and Epithalon together?
- Some users combine peptides within a single protocol, but stacking Desmopressin and Epithalon has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Desmopressin or Epithalon FDA-approved?
- Desmopressin is FDA-approved for one or more indications. Epithalon is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Desmopressin — full monograph: mechanism, research, dosing & references
- Epithalon — full monograph: mechanism, research, dosing & references